Correlation Between NYSE Composite and Endocan Corp
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Endocan Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Endocan Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Endocan Corp, you can compare the effects of market volatilities on NYSE Composite and Endocan Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Endocan Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Endocan Corp.
Diversification Opportunities for NYSE Composite and Endocan Corp
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between NYSE and Endocan is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Endocan Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Endocan Corp and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Endocan Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Endocan Corp has no effect on the direction of NYSE Composite i.e., NYSE Composite and Endocan Corp go up and down completely randomly.
Pair Corralation between NYSE Composite and Endocan Corp
If you would invest 0.01 in Endocan Corp on November 29, 2024 and sell it today you would earn a total of 0.00 from holding Endocan Corp or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Endocan Corp
Performance |
| Timeline |
NYSE Composite and Endocan Corp Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Endocan Corp
Pair trading matchups for Endocan Corp
Pair Trading with NYSE Composite and Endocan Corp
The main advantage of trading using opposite NYSE Composite and Endocan Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Endocan Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Endocan Corp will offset losses from the drop in Endocan Corp's long position.| NYSE Composite vs. Kenon Holdings | NYSE Composite vs. American Electric Power | NYSE Composite vs. Mesa Air Group | NYSE Composite vs. Suburban Propane Partners |
| Endocan Corp vs. Hitachi Ltd ADR | Endocan Corp vs. Grupo Carso SAB | Endocan Corp vs. Teijin | Endocan Corp vs. Jardine Matheson Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |